In this Empowered Patient Podcast with Karen Jagoda, Scott Gray, CEO, discusses how providing patient support services can improve patient recruitment, retention, and outcomes in clinical trials.
Featured in Applied Clinical Trials, Scott Gray, CEO, discusses how pharmaceutical sponsors and clinical research organizations (CROs) can improve patient retention rates and bolster trial completion with patient-centric trials and patient support services.
Healthcare and technology have always gone hand-in-hand. In fact, some of medicine’s earliest innovations are the most enduring. For clinical trials, the convergence of healthcare and technology creates a constant stream of innovation in the pursuit of novel treatments and therapies. Likewise, the pandemic and subsequent growth of decentralized trials demonstrate how technology can play an essential role in the patient experience.
In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act. This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge, …
Featured in Pharmaceutical Outsourcing, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations (CROs), …
Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials Read More »
Providing Global Concierge Services to Facilitate Rare Disease Clinical Trial Participation and Retention
Featured in an article in PM360, Scott Gray, CEO, discusses new developments in the rare disease clinical trial industry ahead of the upcoming Rare Disease Day on February 28, 2022. Learn more about alleviating financial barriers to trial participation, mitigating geographical barriers to trial participation, and the federal efforts to support rare disease trials in …
Enhancing Patient Access and Retention in Rare Disease Clinical Trials Read More »
Featured in CMSwire, Alexis Lynch, Senior Marketing Manager, discusses the techniques Clincierge utilizes to gain insight into patient feedback and preferences in clinical trials. Companies are increasingly relying on feedback from Voice of the Customer (VoC) programs to deliver better service, improve marketing efforts, improve customer loyalty and provide faster customer resolution. The article explores …
4 Ways to Drive Better Voice of the Customer Feedback Read More »
Featured in Applied Clinical Trials, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations …
Medicaid Coverage of “Routine Costs” for Clinical Trials Read More »
Featured in the winter edition of the SCRS InSite Journal, Scott Gray, CEO, discusses industry-wide challenges and key ways to alleviate emotional, financial, and logistical burdens to improve clinical trial access for pediatric patients and their caregivers. Alleviating burdens can boost trial recruitment, enhance the patient experience, and increase patient retention.
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
